icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

First batch of Sputnik V, Russia's Covid-19 vaccine, to be supplied in September - 40,000 volunteers ready for 3rd-stage trials

First batch of Sputnik V, Russia's Covid-19 vaccine, to be supplied in September - 40,000 volunteers ready for 3rd-stage trials
Russia's Health Minister has announced that large-scale deliveries of the world's first registered coronavirus vaccine will start in September. Mikhail Murashko also said on Monday that the third-stage trials were ready to begin.

It is planned that, in total, 40,000 volunteers will participate, with more than 2,500 already chosen. "First of all, of course, the vaccines will be supplied for healthcare workers and teachers, [and] this will be absolutely voluntary," Murashko said. "The first large batches will be supplied as early as September."

He also added that currently several more vaccines against coronavirus are at the clinical trials or registration stage. "That is why I think that we’ll reach optimum volumes in November or December. We’ll need to do separate inoculations against flu and coronavirus infection," he said.

Also on rt.com This Russian device can detect Covid-19 and other dangerous pathogens IN THE AIR (VIDEO)

Groups for post-registration monitoring are now being formed. Last Thursday, the Minister reported that deliveries of the first doses of the vaccine to medical institutions for post-registration trials had already started.

Registered on August 11, Sputnik V is first Covid-19 vaccine to have obtained state registration. The formula was developed by the Gamaleya National Research Center in Moscow. In all, over 160 vaccines are being developed worldwide with over 30 of them at the stage of clinical trials on humans.

Also on rt.com Russians overwhelmingly oppose microchipping of humans, fear becoming cyborgs without even knowing it – state-backed poll

Like this story? Share it with a friend!

Dear readers and commenters,

We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.

Sorry for the inconvenience, and looking forward to your future comments,

RT Team.